Cargando…
Immune checkpoint inhibitor use in patients with end-stage kidney disease: an analysis of reported cases and literature review
Immune checkpoint inhibitors (ICIs), immunomodulatory antibodies that are used to enhance the immune system, have substantially improved the prognosis of patients with advanced malignancy. As the use of ICI therapy becomes increasingly widespread across different types of cancer, their use in patien...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406068/ https://www.ncbi.nlm.nih.gov/pubmed/34476087 http://dx.doi.org/10.1093/ckj/sfab090 |